Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

NCT00239902 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

396

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Transplantation

Interventions

DRUG: FTY720

Sponsor

Novartis Pharmaceuticals